Predictive Technology Group IncOver The Counter Market:PRED
- LAST PRICE0.0005
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0005
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Predictive Technology Group Inc | 149.8K | 0.0x | --- |
SQZ Biotechnologies Co | 1.4M | 0.0x | --- |
Exicure Inc | 4.4M | 0.4x | --- |
Agile Therapeutics Inc | 2.7M | 0.0x | --- |
Emmaus Life Sciences Inc | 5.4M | -1.1x | --- |
Aadi Bioscience Inc | 41.3M | -0.7x | --- |
Company Information
Predictive Technology Group, Inc. is a life science company. The Company, through its subsidiaries, is focused on specific points of the care continuum, including detection, prevention and treatment. Predictive Analytics, Predictive Laboratories, and Predictive Biotech each bring critical solutions to personalized patient care by leveraging its research, genomics, genetic library and expertise in developing bioscience solutions. Predictive Analytics is the repository for its genetic library. Predictive Biotech provides regenerative medicine. Its products are derived from tissue sources rich in properties that support the body’s natural ability to heal itself. All products are safely, ethically and minimally processed to deliver allografts that preserve the naturally occurring characteristics and factors of the donor tissue. Its research and use of processing methods has propelled its placental-derived and Wharton’s Jelly umbilical cord-derived products to new heights.
Contact Information
- Headquarters
- 615 ARAPEEN DRIVE, SUITE 300SALT LAKE CITY, UT, United States 84108
- Phone
- 757-306-6090
- Fax
- ---
Executives
- Independent Chairman of the Board
- John Sorrentino
- President, Chief Executive Officer, Interim Chief Financial Officer, Director
- Bradley Robinson
- CEO of Predictive Therapeutics, Director
- Michael Dey
- Chief Operating Officer
- Paul Evans
- Executive Vice President Predictive Technology Group, Inc, Founder, Chief Executive Officer – Predictive Biotech, Inc.
- Eric Olson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $149.8K |
|---|---|
Revenue (TTM) | $19.2M |
Shares Outstanding | 299.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.80 |
EPS | $-0.24 |
Book Value | $0.18 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -224.32% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
